Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease
Karla L. Otterpohl, Brook W. Busselman, Ishara Ratnayake, Ryan G. Hart, Kimberly R. Hart, Claire M. Evans, Carrie L. Phillips, Jordan R. Beach, Phil Ahrenkiel, Bruce A. Molitoris, Kameswaran Surendran, Indra Chandrasekar
Karla L. Otterpohl, Brook W. Busselman, Ishara Ratnayake, Ryan G. Hart, Kimberly R. Hart, Claire M. Evans, Carrie L. Phillips, Jordan R. Beach, Phil Ahrenkiel, Bruce A. Molitoris, Kameswaran Surendran, Indra Chandrasekar
View: Text | PDF
Research Article Cell biology Nephrology

Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease

  • Text
  • PDF
Abstract

Actin-associated nonmuscle myosin II (NM2) motor proteins play critical roles in a myriad of cellular functions, including endocytosis and organelle transport pathways. Cell type–specific expression and unique subcellular localization of the NM2 proteins, encoded by the Myh9 and Myh10 genes, in the mouse kidney tubules led us to hypothesize that these proteins have specialized functional roles within the renal epithelium. Inducible conditional knockout (cKO) of Myh9 and Myh10 in the renal tubules of adult mice resulted in progressive kidney disease. Prior to overt renal tubular injury, we observed intracellular accumulation of the glycosylphosphatidylinositol-anchored protein uromodulin (UMOD) and gradual loss of Na+ K+ 2Cl– cotransporter from the apical membrane of the thick ascending limb epithelia. The UMOD accumulation coincided with expansion of endoplasmic reticulum (ER) tubules and activation of ER stress and unfolded protein response pathways in Myh9&10-cKO kidneys. We conclude that NM2 proteins are required for localization and transport of UMOD and loss of function results in accumulation of UMOD and ER stress–mediated progressive renal tubulointerstitial disease. These observations establish cell type–specific role(s) for NM2 proteins in regulation of specialized renal epithelial transport pathways and reveal the possibility that human kidney disease associated with MYH9 mutations could be of renal epithelial origin.

Authors

Karla L. Otterpohl, Brook W. Busselman, Ishara Ratnayake, Ryan G. Hart, Kimberly R. Hart, Claire M. Evans, Carrie L. Phillips, Jordan R. Beach, Phil Ahrenkiel, Bruce A. Molitoris, Kameswaran Surendran, Indra Chandrasekar

×

Figure 5

Loss of MYH9 and MYH10 in renal tubules result in gradual loss of NKCC2 from the TAL tubules.

Options: View larger image (or click on image) Download as PowerPoint
Loss of MYH9 and MYH10 in renal tubules result in gradual loss of NKCC2 ...
(A–L) Representative images from Bouin’s-fixed cKO mice and control littermate kidney sections from 6-week, 9-week, and 12-week cohorts were stained with NKCC2 antibody and WGA. Images from control kidney sections at 6-week (A and B), 9-week (E and F), and 12-week (I and J) time points show normal morphology of the TAL tubules with NKCC2 (red) localizing to the apical membranes. (C and D) Six-week-old cKO kidneys show TAL tubules with minimal changes in NKCC2 localization to the apical membrane. (G and H) Kidney sections from 9-week-old cKO mice show TAL tubules with partial to near-complete loss (G, white arrow) of NKCC2 from the apical membrane. (K and L) Twelve-week cKO kidney sections show loss of NKCC2 protein from the apical membrane of TAL tubules (K, white arrows); however, some tubules have accumulation of NKCC2 in the luminal space (K, white arrowheads) or visible intracellular NKCC2 puncta (L, yellow arrow). The white boxes mark the enlarged regions represented in the adjacent images. Scale bar: 10 μm. Images are representative of n ≥ 3 kidneys for control and cKO samples. (M–O) Whole-kidney lysates from 6-week, 9-week, and 12-week cohorts were subjected to immunoblot analysis to detect NKCC2 (~160 kDa) protein. Tubulin was used as a loading control. (M) The 6-week-old cKO samples show a decrease in NKCC2 protein levels compared with controls. (N) At 9 weeks of age, NKCC2 levels are variable in the cKO samples compared with the control kidney lysates. (O) The 12-week-old cKO lysates show loss of NKCC2 protein compared with control kidney lysates. “L” marks the ladder lanes; molecular weight labels indicate the corresponding bands on the ladder. (P) The graph shows quantification of the relative density of the NKCC2 bands observed in the control and cKO kidney samples. The 6-week-old cKO samples show statistically significant decrease in NKCC2 protein levels compared with control (P value = 0.049: n = 3 for control and cKO). The 9-week and 12-week-cKO samples show decreased relative density of NKCC2 compared with controls and were statistically significant (P value = 0.0041 and 0.0059, respectively; n = 6 for control and cKO). P values were calculated using multiple t test, 2-tailed. Error bars represent standard deviation of samples.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts